The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Venlafaxine to prevent oxaliplatin-induced neuropathy?: A pilot randomized placebo-controlled trial.
 
Collin Thomas Zimmerman
No Relationships to Disclose
 
Pamela J. Atherton
No Relationships to Disclose
 
Deirdre R. Pachman
No Relationships to Disclose
 
Drew K. Seisler
No Relationships to Disclose
 
Nina D. Wagner-Johnston
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Gilead Sciences
 
Shaker R. Dakhil
No Relationships to Disclose
 
Jacqueline M. Lafky
No Relationships to Disclose
 
Rui Qin
Employment - United Health Group (I)
Stock and Other Ownership Interests - United Health Group
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Charles L. Loprinzi
Consulting or Advisory Role - Cubist; Helsinn Therapeutics
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Cubist